These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 11727520)

  • 1. In situ gene therapy for prostate cancer: immunomodulatory approaches.
    Thompson TC; Timme TL; Ebara S; Satoh T; Yang G; Wang J; Miles BJ; Ayala G; Wheeler TM; Kadmon D
    Expert Opin Biol Ther; 2001 May; 1(3):481-95. PubMed ID: 11727520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In situ gene therapy for prostate cancer.
    Thompson TC
    Oncol Res; 1999; 11(1):1-8. PubMed ID: 10451026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In situ gene therapy for prostate cancer.
    Satoh T; Irie A; Egawa S; Baba S
    Curr Gene Ther; 2005 Feb; 5(1):111-9. PubMed ID: 15638715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic targets for metastatic prostate cancer.
    Timme TL; Satoh T; Tahir SA; Wang H; Teh BS; Butler EB; Miles BJ; Amato RJ; Kadmon D; Thompson TC
    Curr Drug Targets; 2003 Apr; 4(3):251-61. PubMed ID: 12643475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow.
    Prescrire Int; 2012 Oct; 21(131):242-8. PubMed ID: 23185849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene therapy for prostate cancer: current status and future prospects.
    Harrington KJ; Spitzweg C; Bateman AR; Morris JC; Vile RG
    J Urol; 2001 Oct; 166(4):1220-33. PubMed ID: 11547047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cryotherapy for localised prostate cancer.
    Shelley M; Wilt TJ; Coles B; Mason MD
    Cochrane Database Syst Rev; 2007 Jul; (3):CD005010. PubMed ID: 17636783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in preclinical investigation of prostate cancer gene therapy.
    Figueiredo ML; Kao C; Wu L
    Mol Ther; 2007 Jun; 15(6):1053-64. PubMed ID: 17457317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene delivery and gene therapy of prostate cancer.
    Kaliberov SA; Buchsbaum DJ
    Expert Opin Drug Deliv; 2006 Jan; 3(1):37-51. PubMed ID: 16370939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenovirus-mediated suicide-gene therapy using the herpes simplex virus thymidine kinase gene in cell and animal models of human prostate cancer: changes in tumour cell proliferative activity.
    Cheon J; Kim HK; Moon DG; Yoon DK; Cho JH; Koh SK
    BJU Int; 2000 Apr; 85(6):759-66. PubMed ID: 10759680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenoviral vector-mediated mRTVP-1 gene therapy for prostate cancer.
    Satoh T; Timme TL; Saika T; Ebara S; Yang G; Wang J; Ren C; Kusaka N; Mouraviev V; Thompson TC
    Hum Gene Ther; 2003 Jan; 14(2):91-101. PubMed ID: 12614561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Route of administration influences the antitumor effects of bone marrow-derived dendritic cells engineered to produce interleukin-12 in a metastatic mouse prostate cancer model.
    Saika T; Satoh T; Kusaka N; Ebara S; Mouraviev VB; Timme TL; Thompson TC
    Cancer Gene Ther; 2004 May; 11(5):317-24. PubMed ID: 15044961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of primary tumor growth and the progression to metastasis with p53 adenovirus in human prostate cancer.
    Eastham JA; Grafton W; Martin CM; Williams BJ
    J Urol; 2000 Sep; 164(3 Pt 1):814-9. PubMed ID: 10953161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of adenoviral vectors to direct highly amplified prostate-specific expression for imaging and gene therapy.
    Sato M; Johnson M; Zhang L; Zhang B; Le K; Gambhir SS; Carey M; Wu L
    Mol Ther; 2003 Nov; 8(5):726-37. PubMed ID: 14599805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Gene therapy and immunotherapy in prostatic carcinoma].
    Fiedler U; Wirth MP
    Urologe A; 2001 May; 40(3):207-16. PubMed ID: 11405130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of adenoviral transduction profile in prostate cancer cells and normal prostate tissue.
    Ai J; Tai PWL; Lu Y; Li J; Ma H; Su Q; Wei Q; Li H; Gao G
    Prostate; 2017 Sep; 77(12):1265-1270. PubMed ID: 28726259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene therapy for prostate cancer.
    Gdor Y; Timme TL; Miles BJ; Kadmon D; Thompson TC
    Expert Rev Anticancer Ther; 2002 Jun; 2(3):309-21. PubMed ID: 12113054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced systemic T-cell activation after in situ gene therapy with radiotherapy in prostate cancer patients.
    Satoh T; Teh BS; Timme TL; Mai WY; Gdor Y; Kusaka N; Fujita T; Pramudji CK; Vlachaki MT; Ayala G; Wheeler T; Amato R; Miles BJ; Kadmon D; Butler EB; Thompson TC
    Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):562-71. PubMed ID: 15145177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate cancer gene therapy clinical trials.
    Freytag SO; Stricker H; Movsas B; Kim JH
    Mol Ther; 2007 Jun; 15(6):1042-52. PubMed ID: 17406342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene therapy in prostate cancer: past, present and future.
    Shirakawa T; Fujisawa M; Gotoh A
    Front Biosci; 2008 Jan; 13():2115-9. PubMed ID: 17981696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.